The role of epidermal growth factor and cholinergic receptor agonists and antagonists in MAPK signal transduction in K562 cells

Year 2024, Volume: 37 Issue: 1, 86 - 91, 28.01.2024

Selda Güler Atmaca , Banu Aydın , Hulya Cabadak

https://doi.org/10.5472/marumj.1379868

Abstract

Objective: Muscarinic receptors (M1-M5) are members of the G protein-coupled receptor superfamily and are effective in physiological
functions through G proteins. Recent studies suggested that cholinergic receptors mediate cellular activities in hematopoietic cells.
The aim of this study was to investigate the potential role of mitogen-activated protein kinases (MAPK) signaling extracellular signalregulated
kinases 1 and 2 (ERK1/2)/phosphorylated ERK1/ (pERK1/2) pathways in chronic myeloid leukemia (K562) cells.
Materials and Methods: Chronic myeloid leukemia cells were cultured. Cells were incubated in the presence of muscarinic receptor
agonist, antagonist and epidermal growth factor (EGF). To detect MAPK activation, ERK/pERK protein expression levels were
determined by western blot method techniques.
Results: Our study results showed that cholinergic agents and EGFs affect the MAPK pathway in the human K562 cell line.
Conclusion: Cholinergic and EGF receptors may affect the MAPK pathway in K562 cells.
Conclusion: Cholinergic and EGF receptors may affect the MAPK pathway in K562 cells.

Keywords

G protein coupled receptor, Carbachol, Epidermal growth factor, Mitogen-activated protein kinase, Chronic myeloid leukemia

References

• Tansey EM. Henry Dale and the discovery of acetylcholine. C R Biologie 2006; 329:419-25. doi: 10.1016/j.crvi.2006.03.012
• Fujii T, Mashimo M, Moriwaki Y, et al. Expression and function of the cholinergic system in immune cells. Front Immunol 2017;8: 1085. doi: 10.3389/fimmu.2017.01085ç.
• Van Koppen CJ, Kaiser B. Regulation of muscarinic acetylcholine receptor signaling. Pharmacol Ther 2003; 98:197-220. doi: 10.1016/s0163-7258(03)00032-9.
• Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 1998; 50:279-90.
• Felder CC. Muscarinic acetylcholine receptors: Signal transduction through multiple effectors. FASEB J 1995 ;9; 619- 25.
• Shah N, Khurana S, Cheng K, Raufman JP. Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol 2009; 296: C221-C232. doi: 10.1152/ajpcell.005 14. 2008.
• Nathanson MN. A multiplicity of muscarinic mechanisms: Enough signalling pathways to take your breath away. Proc Natl Acad Sci 2000 ;97, 6245-7. doi: 10.1073/pnas.97.12.6245
• Eglen RM, Hedge SS, Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 1996; 48: 531- 65. PMID: 8981565.
• Gutkind JS. Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci STKE. 2000 ;40:re1. doi: 10.1126/stke.2000.40.re1.
• Park YS, Cho NJ. EGFR and PKC are involved in the activation of ERK1/2 and p90 RSK and the subsequent proliferation of SNU-407 colon cancer cells by muscarinic acetylcholine receptors. Mol Cell Biochem 2012 ;370:191-8. doi: 10.1007/ s11010.012.1410-z.
• Ukegawa JI, Takeuchi Y, Kusayanagi S, Mitamura K. Growthpromoting effect of muscarinic acetylcholine receptors in colon cancer cells. J Cancer Res Clin Oncol 2003 ;129:272-8. doi: 10.1007/s00432.003.0433-y.
• Kolch W. Meaningful relationships: The regulation of the Ras/ Raf/MEK/ERK pathway by protein interactions. Biochem J 2000; 351:289-305.
• Rosenblum K, Futter M, Jones M, Hulme EC, Bliss TV. ERKI/II regulation by the muscarinic acetylcholine receptors in neurons. J Neurosci 2000; 20:977-85. doi: 10.1523/ JNEUROSCI.20-03-00977.2000
• Cabadak H, Kucukibrahimoglu E, Aydin B, Kan B, Zafer Goren M. Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line. Auton Autacoid Pharmacol. 2009; 29:109-15. doi: 10.1111/j.1474-8673.2009.00431.x
• Cabadak H, Aydin B, Kan B. Regulation of M2, M3, and M4 muscarinic receptor expression in K562 chronic myelogenous leukemia cells by carbachol. J Recept Signal Transd Res 2011;31: 26-32. doi: 10.3109/10799.893.2010.506484.
• Onder N, G, Aydin B, Cabadak, H. Studies on the role of alpha 7 nicotinic acetylcholine receptors in K562 cell proliferation and signaling. Mol Biol Rep 2021; 48: 5045-55. doi: 10.1007/ s11033.021.06498-4.
• Liebmann C, Bohmer FD. Signal transduction pathways of G protein-coupled receptors and their cross-talk with receptor tyrosine kinases: Lessons from bradykinin signaling. Curr Med Chem 2000 ; 7: 911-43. doi: 10.2174/092.986.7003374589
• Pearson G, Robinson F, Beers Gibson T, et al. Mitogenactivated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 2001;22: 153-83. doi:10.1210/edrv.22.2.0428
• Daub H, Wallasch C, Lankenau A, Herrlich A, Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J 1997 ;16: 7032-44. doi:10.1093/emboj/16.23.7032
• Cheng K. Zimniak P. Raufman JP. Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of h508 human colon cancer cells. Cancer Res 2003 ;63: 6744-50.
• Nicke B, Detjen K, Logsdon C. Muscarinic cholinergic receptors activate both inhibitory and stimulatory growth mechanisms in NIH3T3 cells. J Biol Chem 1999; 274: 21701-6. doi: 10.1074/jbc.274.31.21701
• Kuol N, Davidson M. Karakkat J, et al. Blocking muscarinic receptor 3 attenuates tumor growth and decreases immunosuppressive and cholinergic markers in an orthotopic mouse model of colorectal cancer. Int J Mol Sci 2023; 24: 596. doi: 10.3390 /ijms24010596
• Lanzafame A, Christopoulos A, Mitchelson F. Cellular signaling mechanisms for muscarinic acetylcholine receptors. Receptors Channels 2003; 9: 241-60.
• Metzger M, Just L, Boss A, Drews U. Identification and functional characterization of the muscarinic receptor M3 in the human keratinocyte cell line haCat. Cells Tissues Organs 2005;180: 96-105. doi: 10.1159/000086750.
• Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 1999; 402: 884-8. doi: 10.1038/47260
• Yu H, Xia H, Tang Q, et al., Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation. Sci Rep 2017; 7: 40802. doi: 10.1038/srep40802.
• Yang T, He W, Cui F, et al. MACC1 mediates acetylcholineinduced invasion and migration by human gastric cancer cells. Oncotarget 2016; 7: 18085-94. doi: 10.18632/ oncotarget.7634.
• Lan L, Wang H, Yang R, et al. R2-8018 reduces the proliferation and migration of non-small cell lung cancer cells by disturbing transactivation between M3R and EGFR. Life Sci 2019 ; 234: 116742. doi: 10.1016/j.lfs.2019.116742.
• Calaf GM, Crispin LA, Muñoz JP, Aguayo F, Bleak TC. Muscarinic receptors associated with cancer. Cancers 2022;14:2322. doi:10.3390/cancers14092322
• Kanlı Z, Cabadak H, Aydın B. Potential antiproliferative and apoptotic effects of pilocarpine combined with TNF alpha in chronic myeloid leukemia cells. Naunyn Schmiedebergs Arch Pharmacol 2023; 396: 1513-24 doi.org/10.1007/ s00210.023.02418-4 .
• Kanlı Z, Aydın B, Cabadak H. Effects of several compounds in human erythroleukemia K562 cell proliferation and apoptosis. Marmara Med J 2019; 32:20-26. doi.org/10.5472/ marumj.518797
• Aydin B, Tulunay A, Ekşioğlu-Demiralp E, Kan B, Cabadak H. Effects of carbachol on apoptosis in human chronic myelogenous leukemic K562 cell line. Marmara Med J 2019; 32: 38-43. doi.org 10.5472/marumj.518983.